Cart
sales@molnova.com
(S, R)-LSN 3318839
CAS No. 2765539-92-0
(S, R)-LSN 3318839( —— )
Catalog No. M35704 CAS No. 2765539-92-0
(S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 409 | In Stock |
|
| 10MG | 604 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1265 | In Stock |
|
| 100MG | 1702 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(S, R)-LSN 3318839
-
NoteResearch use only, not for human use.
-
Brief Description(S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.
-
Description(S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGlucagon Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2765539-92-0
-
Formula Weight480.39
-
Molecular FormulaC26H23Cl2N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C)(N1C=2C(N=C1)=CN=C(C2)C3=C([C@@H](C(O)=O)C)C=CC=C3)C4=C(Cl)C(=CC=C4Cl)C5CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Exendin-4
Exendin-4 is a glucagon-like protein-1 (GLP-1) receptor agonist.
-
Tirzepatide
Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
-
Retatrutide
Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide can be used to study obesity.
